These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18848765)

  • 1. Bio-equivalence of IM and SQ H.P. Acthar Gel.
    Brod SA; Morales MM
    Biomed Pharmacother; 2009 May; 63(4):251-3. PubMed ID: 18848765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular administration of a low dose of ACTH for ACTH stimulation testing in dogs.
    Behrend EN; Kemppainen RJ; Bruyette DS; Busch KA; Lee HP
    J Am Vet Med Assoc; 2006 Aug; 229(4):528-30. PubMed ID: 16910850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.
    Simsarian JP; Saunders C; Smith DM
    Drug Des Devel Ther; 2011; 5():381-9. PubMed ID: 21792296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®).
    Gold LS; Suh K; Schepman PB; Damal K; Hansen RN
    Adv Ther; 2016 Aug; 33(8):1279-92. PubMed ID: 27312977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ACTH (H.P. Acthar(®)Gel) inhibits IL-1 and IL-17 secretion in humans.
    Brod SA; Bauer V; Hood Z
    Biomed Pharmacother; 2012 Feb; 66(1):36-9. PubMed ID: 22244960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased plasma cortisol in response to intramuscular ACTH in ocular hypertensives and primary open-angle glaucomas.
    Schwartz B; Rabin PA; Wysocki A; Martin J
    J Glaucoma; 2007 May; 16(3):282-6. PubMed ID: 17438420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients.
    Baughman RP; Barney JB; O'Hare L; Lower EE
    Respir Med; 2016 Jan; 110():66-72. PubMed ID: 26626451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
    Cusick MF; Libbey JE; Oh L; Jordan S; Fujinami RS
    Autoimmunity; 2015 Jun; 48(4):222-30. PubMed ID: 25410153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline plasma cortisol and ACTH concentrations and response to low-dose ACTH stimulation testing in ill foals.
    Wong DM; Vo DT; Alcott CJ; Peterson AD; Sponseller BA; Hsu WH
    J Am Vet Med Assoc; 2009 Jan; 234(1):126-32. PubMed ID: 19119977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes.
    Kutz C
    Ther Adv Chronic Dis; 2016 Jul; 7(4):190-7. PubMed ID: 27433309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocortical response to high dosage ACTH therapy in patients with multiple sclerosis.
    Alexander L; Cass LJ; Enders M; Sarai K
    Confin Neurol; 1966; 28(1):1-17. PubMed ID: 4290212
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroidogenic responses to varying parenteral routes of administered (alpha 1-18) ACTH.
    Pratt JH; Komanicky P; Wilson TE; Dale SL; Melby JC
    Metabolism; 1976 Feb; 25(2):221-6. PubMed ID: 175238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications.
    Philbin M; Niewoehner J; Wan GJ
    Adv Ther; 2017 Aug; 34(8):1775-1790. PubMed ID: 28660550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis.
    Brooks PJ; Spruill WJ; Parish RC; Birchmore DA
    Arthritis Rheum; 1990 Jan; 33(1):91-4. PubMed ID: 2302272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of multiple sclerosis with Lyoproper].
    Aschoff JC; Conrad B
    Med Klin; 1971 Jun; 66(30):1055-8. PubMed ID: 4328079
    [No Abstract]   [Full Text] [Related]  

  • 16. Home intravenous administration of adrenocorticotropic hormone in patients with multiple sclerosis.
    Molitor RE; Stewart J
    J Intraven Nurs; 1988; 11(4):249-51. PubMed ID: 2843618
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenocortical response to low-dose ACTH test in female patients with rheumatoid arthritis.
    Radikova Z; Rovensky J; Vlcek M; Penesova A; Kerlik J; Vigas M; Imrich R
    Ann N Y Acad Sci; 2008 Dec; 1148():562-6. PubMed ID: 19120158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous or intramuscular? Confronting a parenteral administration dilemma.
    Prettyman J
    Medsurg Nurs; 2005 Apr; 14(2):93-8; quiz 99. PubMed ID: 15916264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical evaluation and review of ACTH (corticotrophin) in the treatment of acute exacerbations of multiple sclerosis.
    Blustein H; Wasserman RR; Halperin L; Garvin JS
    Med Times; 1969 Dec; 97(12):137-41. PubMed ID: 4312534
    [No Abstract]   [Full Text] [Related]  

  • 20. Peri-operative adrenocortical response to low-dose (1 microg) ACTH and relation to postoperative complications in patients undergoing elective abdominal surgery.
    Brander L; Haltmeier T; Suter A; Studer P; Inderbitzin D; Candinas D; Vogt A; Henzen C; Takala J; Jakob SM
    Surgery; 2009 Jul; 146(1):88-99. PubMed ID: 19541014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.